BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30788791)

  • 1. Genetic Tools for Streamlined and Accelerated Pathway Engineering in Yarrowia lipolytica.
    Wong L; Holdridge B; Engel J; Xu P
    Methods Mol Biol; 2019; 1927():155-177. PubMed ID: 30788791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EasyCloneYALI: CRISPR/Cas9-Based Synthetic Toolbox for Engineering of the Yeast Yarrowia lipolytica.
    Holkenbrink C; Dam MI; Kildegaard KR; Beder J; Dahlin J; Doménech Belda D; Borodina I
    Biotechnol J; 2018 Sep; 13(9):e1700543. PubMed ID: 29377615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YaliBricks, a versatile genetic toolkit for streamlined and rapid pathway engineering in
    Wong L; Engel J; Jin E; Holdridge B; Xu P
    Metab Eng Commun; 2017 Dec; 5():68-77. PubMed ID: 29188186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic RNA Polymerase III Promoters Facilitate High-Efficiency CRISPR-Cas9-Mediated Genome Editing in Yarrowia lipolytica.
    Schwartz CM; Hussain MS; Blenner M; Wheeldon I
    ACS Synth Biol; 2016 Apr; 5(4):356-9. PubMed ID: 26714206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic biology tools for engineering Yarrowia lipolytica.
    Larroude M; Rossignol T; Nicaud JM; Ledesma-Amaro R
    Biotechnol Adv; 2018 Dec; 36(8):2150-2164. PubMed ID: 30315870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Golden-Gate Based Cloning Toolkit to Build Violacein Pathway Libraries in
    Tong Y; Zhou J; Zhang L; Xu P
    ACS Synth Biol; 2021 Jan; 10(1):115-124. PubMed ID: 33399465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing, Transcriptional Regulation, and Forward Genetic Screening Using CRISPR-Cas12a Systems in Yarrowia lipolytica.
    Ramesh A; Lee S; Wheeldon I
    Methods Mol Biol; 2024; 2760():169-198. PubMed ID: 38468089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances and opportunities in gene editing and gene regulation technology for Yarrowia lipolytica.
    Ganesan V; Spagnuolo M; Agrawal A; Smith S; Gao D; Blenner M
    Microb Cell Fact; 2019 Nov; 18(1):208. PubMed ID: 31783869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of synthetic biology tools in Yarrowia lipolytica.
    Cao L; Li J; Yang Z; Hu X; Wang P
    World J Microbiol Biotechnol; 2023 Mar; 39(5):129. PubMed ID: 36944859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing metabolic engineering of Yarrowia lipolytica using the CRISPR/Cas system.
    Shi TQ; Huang H; Kerkhoven EJ; Ji XJ
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9541-9548. PubMed ID: 30238143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
    Yang Z; Xu P
    Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR-Cas9 system.
    Gao S; Tong Y; Wen Z; Zhu L; Ge M; Chen D; Jiang Y; Yang S
    J Ind Microbiol Biotechnol; 2016 Aug; 43(8):1085-93. PubMed ID: 27349768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving CRISPR/Cas9-mediated genome editing efficiency in Yarrowia lipolytica using direct tRNA-sgRNA fusions.
    Abdel-Mawgoud AM; Stephanopoulos G
    Metab Eng; 2020 Nov; 62():106-115. PubMed ID: 32758536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A set of Yarrowia lipolytica CRISPR/Cas9 vectors for exploiting wild-type strain diversity.
    Larroude M; Trabelsi H; Nicaud JM; Rossignol T
    Biotechnol Lett; 2020 May; 42(5):773-785. PubMed ID: 31974649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A teaching protocol demonstrating the use of EasyClone and CRISPR/Cas9 for metabolic engineering of Saccharomyces cerevisiae and Yarrowia lipolytica.
    Milne N; Tramontin LRR; Borodina I
    FEMS Yeast Res; 2020 Mar; 20(2):. PubMed ID: 31556952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR Interference and Activation to Modulate Transcription in Yarrowia lipolytica.
    Misa J; Schwartz C
    Methods Mol Biol; 2021; 2307():95-109. PubMed ID: 33847984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Yarrowia lipolytica for Use in Biotechnological Applications: A Review of Major Achievements and Recent Innovations.
    Madzak C
    Mol Biotechnol; 2018 Aug; 60(8):621-635. PubMed ID: 29943148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guide RNA Design for Genome-Wide CRISPR Screens in Yarrowia lipolytica.
    Ramesh A; Wheeldon I
    Methods Mol Biol; 2021; 2307():123-137. PubMed ID: 33847986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology-independent genome integration enables rapid library construction for enzyme expression and pathway optimization in Yarrowia lipolytica.
    Cui Z; Jiang X; Zheng H; Qi Q; Hou J
    Biotechnol Bioeng; 2019 Feb; 116(2):354-363. PubMed ID: 30418662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.